M3T-49373-39697
1 vaccination
1 coded response
5 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 926 / CA
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-13
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-06
Registered in v-safe
- 2021-04-06
- 2021-04-12
- 2021-04-19
- 2021-04-24
-
2021-09-11
Survey response — 6 months, dose 1MedDRA: Biochemical pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Chemical pregnancy twiceMedDRA releases: 2024-11 · check-in free text available
-
2021-09-11
Report sent to call center — 6 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-09-13
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-11 | Successful 2021-09-13 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 9 — 6 months, dose 1
Symptoms: Chemical pregnancy twice
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Biochemical pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release